Genome-wide screening reveals that miR-195 targets the TNF-/NF-B pathway by down-regulating IB kinase alpha and TAB3 in hepatocellular carcinoma

被引:114
作者
Ding, Jie [1 ]
Huang, Shenglin [1 ]
Wang, Ying [1 ]
Tian, Qi [1 ]
Zha, Ruopeng [1 ]
Shi, Haibing [1 ]
Wang, Qifeng [1 ]
Ge, Chao [1 ]
Chen, Taoyang [2 ]
Zhao, Yingjun [1 ]
Liang, Linhui [1 ]
Li, Jinjun [1 ]
He, Xianghuo [1 ]
机构
[1] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200032, Peoples R China
[2] Qi Dong Liver Canc Inst, Qi Dong, Peoples R China
基金
中国国家自然科学基金;
关键词
NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL LUNG-CANCER; BREAST-CANCER; IKK-ALPHA; SUPPRESSES TUMORIGENICITY; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION;
D O I
10.1002/hep.26378
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nuclear factor kappa B (NF-B) is an important factor linking inflammation and tumorigenesis. In this study we experimentally demonstrated through a high-throughput luciferase reporter screen that NF-B signaling can be directly targeted by nearly 29 microRNAs (miRNAs). Many of these miRNAs can directly target NF-B signaling nodes by binding to their 3 untranslated region (UTR). miR-195, a member of the miR-15 family, is frequently down-regulated in gastrointestinal cancers, especially in hepatocellular carcinoma (HCC). The expression level of miR-195 is inversely correlated with HCC tumor size. We further show that miR-195 suppresses cancer cell proliferation and migration in vitro and reduces tumorigenicity and metastasis in vivo. Additionally, miR-195 may exert its tumor suppressive function by decreasing the expression of multiple NF-B downstream effectors by way of the direct targeting of IKK and TAB3. Conclusion: Multiple miRNAs are involved in the NF-B signaling pathway and miR-195 plays important inhibitory roles in cancer progression and may be a potential therapeutic target. (Hepatology 2013;58:654-666)
引用
收藏
页码:654 / 666
页数:13
相关论文
共 41 条
[1]   miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer [J].
Bandi, Nora ;
Zbinden, Samuel ;
Gugger, Mathias ;
Arnold, Marlene ;
Kocher, Verena ;
Hasan, Lara ;
Kappeler, Andreas ;
Brunner, Thomas ;
Vassella, Erik .
CANCER RESEARCH, 2009, 69 (13) :5553-5559
[2]   Inflammation meets cancer, with NF-κB as the matchmaker [J].
Ben-Neriah, Yinon ;
Karin, Michael .
NATURE IMMUNOLOGY, 2011, 12 (08) :715-723
[3]   MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer [J].
Bhattacharya, Resham ;
Nicoloso, Milena ;
Arvizo, Rochelle ;
Wang, Enfeng ;
Cortez, Angelica ;
Rossi, Simona ;
Calin, George A. ;
Mukherjee, Priyabrata .
CANCER RESEARCH, 2009, 69 (23) :9090-9095
[4]   Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells [J].
Bhaumik, D. ;
Scott, G. K. ;
Schokrpur, S. ;
Patil, C. K. ;
Campisi, J. ;
Benz, C. C. .
ONCOGENE, 2008, 27 (42) :5643-5647
[5]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[6]   Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH) [J].
Carlos Herrera, Juan ;
Fernando Isaza, Luis ;
Luis Ramirez, Jose ;
Vasquez, Gonzalo ;
Mario Muneton, Carlos .
BIOMEDICA, 2010, 30 (03) :390-400
[7]   Duration of nuclear NF-κB action regulated by reversible acetylation [J].
Chen, LF ;
Fischle, W ;
Verdin, E ;
Greene, WC .
SCIENCE, 2001, 293 (5535) :1653-1657
[8]   Acetylation of ReIA at discrete sites regulates distinct nuclear functions of NF-κB [J].
Chen, LF ;
Mu, YJ ;
Greene, WC .
EMBO JOURNAL, 2002, 21 (23) :6539-6548
[9]   TAB3, a new binding partner of the protein kinase TAK1 [J].
Cheung, PCF ;
Nebreda, AR ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2004, 378 :27-34
[10]  
Chmara M, 2004, ANTICANCER RES, V24, P4259